Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -108.85%-302.54M | ---- | 35.41%-144.86M | ---- | -31.82%-224.27M | ---- | -2,314.95%-170.13M | ---- | 102.25%7.68M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -8.50%-664K | ---- | 71.15%-612K | ---- | 7.26%-2.12M | ---- | 11.32%-2.29M | ---- | 37.34%-2.58M |
| Attributable subsidiary (profit) loss | ---- | -54.47%10.23M | ---- | 12.71%22.47M | ---- | -4.91%19.93M | ---- | 1,169.54%20.96M | ---- | -686.83%-1.96M |
| Impairment and provisions: | ---- | 352.42%1.87M | ---- | -99.48%414K | ---- | -15.33%79.25M | ---- | 257.51%93.6M | ---- | -122.21%-59.43M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | --289K | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | 284.16%4.05M | ---- | ---2.2M | ---- | ---- | ---- | -1,047.49%-41.63M | ---- | -118.43%-3.63M |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --33.48M | ---- | ---- |
| -Other impairments and provisions | ---- | -183.22%-2.17M | ---- | -96.69%2.61M | ---- | -22.40%78.97M | ---- | 282.36%101.76M | ---- | -127.80%-55.8M |
| Revaluation surplus: | ---- | 56.11%1.75M | ---- | -51.78%1.12M | ---- | 123.57%2.33M | ---- | -105.37%-9.87M | ---- | 63.63%-4.8M |
| -Fair value of investment properties (increase) | ---- | 56.11%1.75M | ---- | -51.78%1.12M | ---- | 123.57%2.33M | ---- | -105.37%-9.87M | ---- | 21.91%-4.8M |
| Asset sale loss (gain): | ---- | --3.8M | ---- | ---- | ---- | 81.56%-627K | ---- | -1,354.98%-3.4M | ---- | 111.43%271K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---627K | ---- | ---- | ---- | 114.30%356K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | --3.8M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -3,901.18%-3.4M | ---- | -170.83%-85K |
| Depreciation and amortization: | ---- | -18.68%36.82M | ---- | -72.55%45.28M | ---- | 1.76%164.92M | ---- | -2.94%162.07M | ---- | 2.96%166.97M |
| -Amortization of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -10.83%9.48M | ---- | -1.13%10.64M |
| Financial expense | ---- | -92.73%7.31M | ---- | -32.29%100.55M | ---- | 45.81%148.5M | ---- | -1.17%101.84M | ---- | -7.24%103.05M |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.73M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -1,091.09%-241.42M | ---- | -87.04%24.36M | ---- | -4.38%187.91M | ---- | -6.06%196.52M | ---- | 16.50%209.2M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 109.90%1.72M | ---- | 61.01%-17.42M | ---- | -52.30%-44.67M | ---- | -103.16%-29.33M | ---- | -284.92%-14.44M |
| Accounts receivable (increase)decrease | ---- | -272.14%-26.77M | ---- | 229.04%15.55M | ---- | 66.09%-12.05M | ---- | -388.93%-35.54M | ---- | 60.43%12.3M |
| Accounts payable increase (decrease) | ---- | 101.91%123.73M | ---- | 6.69%61.28M | ---- | 905.41%57.44M | ---- | 103.41%5.71M | ---- | -510.93%-167.71M |
| prepayments (increase)decrease | ---- | -0.19%18.24M | ---- | -59.44%18.28M | ---- | -68.48%45.06M | ---- | 208.95%142.95M | ---- | 139.20%46.27M |
| Special items for working capital changes | ---- | 98.39%-713K | ---- | -276.87%-44.19M | ---- | 123.82%24.98M | ---- | -379.99%-104.89M | ---- | 186.92%37.46M |
| Cash from business operations | ---- | -316.37%-125.2M | ---- | -77.63%57.87M | ---- | 47.46%258.68M | ---- | 42.52%175.42M | ---- | -5.96%123.09M |
| Other taxs | ---- | -6,192.86%-3.52M | ---- | -330.77%-56K | ---- | 98.78%-13K | ---- | -4,731.82%-1.06M | ---- | 98.50%-22K |
| Special items of business | 97.29%29.91M | ---- | -36.19%15.16M | ---- | -77.59%23.76M | ---- | -13.28%106.03M | ---- | 72.17%122.27M | ---- |
| Net cash from operations | 97.29%29.91M | -322.67%-128.73M | -36.19%15.16M | -77.65%57.81M | -77.59%23.76M | 48.35%258.67M | -13.28%106.03M | 41.68%174.36M | 72.17%122.27M | -4.91%123.06M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -59.62%21K | ---- | 52.94%52K | ---- | -38.18%34K | ---- | -90.47%55K | ---- | -52.24%577K |
| Sale of fixed assets | ---- | --109K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | ---- | -27.10%-8.72M | ---- | -2,242.32%-6.86M | ---- | 94.56%-293K | ---- | -918.90%-5.39M | ---- | 96.45%-529K |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---14.09M | ---- | ---- | ---- | -98.32%1.14M |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 2,822.14%33.93M |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2.05M |
| Other items in the investment business | -1,747.46%-14.91M | ---- | 38.54%-807K | ---- | -302.76%-1.31M | ---- | -102.50%-326K | ---- | 1,181.31%13.02M | ---- |
| Net cash from investment operations | -1,747.46%-14.91M | -26.16%-8.59M | 38.54%-807K | 52.52%-6.81M | -302.76%-1.31M | -168.87%-14.34M | -102.50%-326K | -116.14%-5.34M | 1,181.31%13.02M | -32.99%33.06M |
| Net cash before financing | 4.52%15M | -369.26%-137.32M | -36.06%14.36M | -79.13%51M | -78.76%22.45M | 44.55%244.32M | -21.87%105.71M | 8.26%169.02M | 93.78%135.29M | -12.66%156.12M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -9.42%25.23M | ---- | -31.64%27.86M | ---- | -63.05%40.75M | ---- | 9.91%110.29M | ---- | -30.51%100.34M |
| Refund | ---- | 44.82%-13.11M | ---- | 74.37%-23.75M | ---- | 6.23%-92.69M | ---- | 23.47%-98.86M | ---- | -6.52%-129.17M |
| Issuing shares | ---- | --122.79M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | ---- | 98.56%-108K | ---- | 54.11%-7.51M | ---- | -25.67%-16.36M | ---- | 72.39%-13.02M | ---- | 11.50%-47.17M |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | 95.73%-169K | ---- | 19.61%-3.96M | ---- | ---4.93M |
| Pledged bank deposit (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -36.36%19.2M | ---- | -12.76%30.17M |
| Other items of the financing business | 33.70%-11.87M | 1,068.37%37.49M | -6.56%-17.9M | 118.45%3.21M | 83.57%-16.8M | -232.15%-17.39M | 27.39%-102.27M | 741.33%13.16M | -28.17%-140.85M | 96.70%-2.05M |
| Net cash from financing operations | 33.70%-11.87M | 382.41%134.49M | -6.56%-17.9M | 81.22%-47.62M | 83.57%-16.8M | -58.44%-253.6M | 27.39%-102.27M | 29.12%-160.06M | -28.17%-140.85M | -93.50%-225.81M |
| Effect of rate | 225.61%103K | 109.16%482K | 97.15%-82K | -60.89%-5.26M | 39.61%-2.88M | 57.21%-3.27M | -220.92%-4.76M | -148.34%-7.64M | -66.97%3.94M | 210.58%15.81M |
| Net Cash | 188.28%3.13M | -183.92%-2.83M | -162.84%-3.55M | 136.38%3.38M | 64.28%5.65M | -203.60%-9.28M | 161.86%3.44M | 112.86%8.96M | 86.13%-5.56M | -212.32%-69.69M |
| Begining period cash | -18.10%10.64M | -12.66%13M | -12.66%13M | -45.76%14.88M | -45.76%14.88M | 5.05%27.43M | 5.05%27.43M | -67.35%26.12M | -67.35%26.12M | 148.08%80M |
| Cash at the end | 48.21%13.88M | -18.10%10.64M | -46.95%9.37M | -12.66%13M | -32.39%17.65M | -45.76%14.88M | 6.59%26.11M | 5.05%27.43M | -52.75%24.5M | -67.35%26.12M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Auditor | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.